Ivyctory Solutions CEO Joins Members of Congress at U.S. Capitol to Advance Biomedical Reform

BETHESDA, Md. - Rezul -- New bipartisan legislation—the Companion Animal Protection Against Cruel Testing (COMPACT) Act, introduced September 21, 2026, as H.R. 10522—was the focus of a September 23 press conference at the U.S. Capitol. The bill seeks to modernize federally funded biomedical research while strengthening protections for companion animals.

Dr. Zaher Nahle, Founder and CEO of Ivyctory Solutions, joined Representatives Nick Langworthy (R-NY) and Mark Pocan (D-WI), alongside national leaders including Wayne Pacelle of Animal Wellness Action, to deliver remarks on biomedical research modernization and federal research policy.

Speaking at the Capitol's House Triangle and summarizing the significance of the COMPACT Act, Dr. Nahle identified four priorities: protecting companion animals, preserving research that benefits their own health, improving accountability for taxpayer-funded research, and advancing American biomedical science toward better evidentiary standards—standards that are rigorous, innovative, and, above all, relevant to human health and physiology.

More on Rezul News

• Everything Policy Unveils Their Classroom Resources Behind Every Policy Topic
• Constantine "Costa" Kapothanasis II Acquires The Lubri-Loy Company, Carrying a 77-Year-Old American Lubricant Brand Into Its Next Era
• LS2 Partners with Angels Of Dirt's "Next Chapter Racer" Series Celebrating Women and Girls in Motorsports
• Danish company biosuite introduces biotech procurement software to track outsourced R&D commitments
• South Jersey Realtor Christine Boysen Guides Buyers and Sellers Through Life's Next Chapters

Dr. Nahle's participation, at the invitation of Congressman Langworthy's office, reflects the value placed on independent scientific analysis and underscores Ivyctory Solutions' growing role in providing substantive, evidence-based insights at the intersection of biomedical innovation, regulatory modernization, and public policy.

Dr. Nahle, who also serves as Senior Scientific Advisor to the Center for a Humane Economy, emphasized the need to modernize biomedical research, strengthen accountability for federal research investments, and evaluate scientific practices against measurable outcomes.

Drawing on findings from the Government Accountability Office, Dr. Nahle also raised concerns about the ability of federal agencies to accurately measure animal research expenditures and evaluate research performance. "What we cannot reliably measure, we cannot properly assess. And what we cannot assess, we cannot systematically improve," he told attendees.

Reflecting on the broader implications, Dr. Nahle emphasized the compatibility of scientific advancement and animal protection. "We do not have to choose between advancing human health or animal welfare. They can—and should—go hand in hand," he said.

More on Rezul News

• Industrial & systems engineering educator and professional to lead global strategic partnerships for professional society
• Dan Ventures Shares Plans for Common Frame, Attainable and Workforce Housing for Vermont and Florida
• Chris Grabinski Joins Stockdale Capital Partners to Bolster Healthcare Investment Platform
• Convergence of AI, Wearable Technology, Remote Patient Monitoring and Real-World Healthcare: PomDoctor Ltd. (N A S D A Q: POM)
• 4th Qtr. 2026 Treasure Coast of Florida, Real Estate Trends

The event united lawmakers, research professionals, and national advocacy organizations to advance discussions about animal welfare, scientific innovation, federal research priorities, and responsible public policy.

Dr. Nahle's full remarks at the congressional event are accessible on LinkedIn (https://www.linkedin.com/feed/update/urn:li:activity:7508680358993895425/).

About Ivyctory Solutions

Ivyctory Solutions is a market research and strategic advisory firm specializing in biomedical innovation, life sciences, regulatory affairs, and public policy. The firm provides evidence-based analysis, market intelligence, and strategic insights to inform decision-making, evaluate emerging technologies, and navigate evolving scientific and regulatory landscapes.

Website: https://www.ivyctory.com